2026.05.27
Q&A on Japan’s Conditional Approval Policies for Pharmaceuticals: Key Clarifications for Global Drug Developers
Introduction to Japan’s Conditional Approval Q&A According to the Q&A document issued by Japan’s Minis […]
2026.01.21
Japan Advances Regulatory Reforms on RWD Utilization, Conditional Approval, and Pediatric Drug Development
Introduction to Regulatory Revisions According to the notification issued by Japan’s Ministry of Health, Labou […]
2025.04.08
Japan’s New Requirement for Pediatric Drug Development Plans in PMDA Consultations
Introduction to Regulatory UpdateAccording to the news (PMDA 成人対象の治験相談でも「小児用医薬品の開発計画の有無を資料に記載」日薬連等に留意事項通知 | ニュ […]